Vascular endothelial growth factor (VEGF) isoforms, particularly the diffusible VEGF-121, could play a major role in the response of recurrent glioblastoma (GB) to anti-angiogenetic treatment with bevacizumab. | VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma